Srinivasa Rao V.1*, Das S. K.2, Nageswara Rao K.3, Kusuma Kumari E.4
1Computer Science and Engineering, PVP Siddhartha Institute oOf Technology, Vijayawada, India
2Department of Computer Science, Berhampur University, Berhampur, Orissa, India
3Computer Science and Engineering, PVP Siddhartha Institute oOf Technology, Vijayawada, India
4Electronics and Communication Engineering, Nova College of Engineering, Jangareddygudem, India
* Corresponding Author : akrgvsr@gmail.com
Received : - Accepted : - Published : 21-12-2009
Volume : 1 Issue : 2 Pages : 81 - 84
Int J Bioinformatics Res 1.2 (2009):81-84
DOI : http://dx.doi.org/10.9735/0975-3087.1.2.81-84
Keywords : bioinformatics, clinical, biomarker
Conflict of Interest : None declared
Rapid advances in technologies like genomic as well as bioinformatics coupled with a unique collaboration between industry and academia are beginning to show the true potential for the human genome project to affect patient healthcare. By knowing the sequence of the human genome and beginning to unravel the location and sequence of all genes and their variants, scientists can establish a better understanding of the mechanisms for diseases, with subsequent availability of new treatments. Because of the vast amount of data coming out of the Human Genome Project, bioinformatics tools and databases have become an integral part of pharmacogenomic and disease susceptibility gene research.